top of page
HLSC Logo.png
Arie headshot 2025 3 (2).jpeg

Arie Regev, MD, FAASLD

Gastroenterologist and hepatologist with more than 30 years of clinical, academic, and pharmaceutical leadership experience.

  • Retired Vice President of Global Patient Safety at Eli Lilly

  • Founding co-chair of IQ DILI

  • Former Associate Professor of Medicine at the Division of Hepatology, University of Miami and the Division of Gastroenterology and Hepatology, Indiana University School of Medicine

  • Author of more than 150 publications and chapters in major scientific journals and books

Read full bio
pattern-blue.png

Hepatology and Liver Safety Consulting, LLC provides expert hepatic safety and drug-induced liver injury (DILI) consulting to pharmaceutical and biotechnology companies throughout the drug development lifecycle, from preclinical research through post-marketing surveillance.

consulting services

Areas of Expertise

Hepatic Safety & DILI Risk Assessment

Clinical Trial Design & Protocol Support

Risk Management

Case Review & Adjudication

Regulatory Support

Data and Safety Monitoring Board

Education & Training

Due Diligence

View all consulting services

Founding co-chair of the IQ-DILI Initiative and co-chair of its Immunotherapy, Gene Therapy, and Pediatrics working groups.

Arie website home page.jpg

For consulting inquiries, please reach out directly.

Contact
bottom of page